Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Again no license today...

Again no license today...

posted on Apr 01, 2008 05:28AM

Now this is going to get interesting until April 9th:

Will shareprice and volume increase without news until the release of the Q3-numbers? If not, I suspect, the "non-communications" game is not over then.

By the way, I can hear already Dutton after the release: "Though Patriot had an exceptional third quarter, nothing can be said about the next quarter due to the fact, that only two (and smaller) companies signed a MMP license, and thus we reiterate our target at 0,92."

I really wish, RG will start playing honestly and doesn't continue building traps for us shareholders (though I'm suspicious his 100k shares-purchase might have been a "trick"...).

GLTA 

Share
New Message
Please login to post a reply